Ripertamab (Anti-CD20)

Ripertamab (Anti-CD20) is a chimeric monoclonal antibody directed against human CD20 with potential antineoplastic activity. MW : 144.56 KD.

Price Not Available 1mg*5 Ripertamab (Anti-CD20) Supplier Page
Trivial name SCT400
Catalog Number A2805
CAS# 2249927-04-4
Size 1mg*5